“The global Scanning Electron Microscopes Market is anticipated to surpass USD 2 billion by 2020”, says Visiongain

07 November 2019
Pharma

Visiongain has launched a new pharma report “Scanning Electron Microscopes Market Report 2020-2030” Prospects by Type (Scanning, Transmission), Application (Automobiles, Electronics & Semiconductors, Pharmaceuticals, Steel & other metals, Other applications) and Geography.

The global scanning electron microscopes market is projected to grow on account increasing demand of nanotechnology-based research, growing applications in semi-conductor, electronics & pharmaceutical industries among other contributing growth factors. The global market is projected to grow at a lucrative CAGR of ~10% over the forecast period 2020-2030 and anticipated to surpass USD 2 billion by 2020.

The scanning electron microscope (SEM) remains one of the most powerful and versatile tools used in research, development and production environments. The SEM is capable of imaging a wide range of sample types & sizes, often with nominal sample preparation, and is capable of generating multiple analytical signals, thus providing high-resolution information about a sample's composition, phase, electrical, optical, and other properties.

Key market drivers include increasing demand for nanotechnology-based research and the consequent growth in investments and funding from regional government bodies. Also, increasing applications in the semiconductors, electronic and pharmaceutical industries is expected to boost growth over the forecast period from 2020 to 2030.

Increasing global emphasis on R&D for applications such as neuroscience, material science, life science, nanotechnology, and semiconductor industry is anticipated to boost demand for adoption of advanced and automated microscopes such as analytical electron microscope, microscope scanning probe, and SEM. Such microscopes have image resolution as high as 0.1 nm, which is important for these manufacturing industries.

In terms of application, pharmaceutical dominated the global scanning electron microscope market in 2018 with over 35% of the global market share. Also, the growing burden of chronic diseases and other diseases in anticipated to boost further growth especially in the developing regions across the globe.

In the year 2018, Asia Pacific dominated the global scanning electron microscope market with over 35% of the global market share. The key factor that accounts for its significant share is rapid growth in applications such as semiconductors, pharmaceuticals, and nanotechnology among other applications.

North America is the second-largest market in terms of revenue owing to the presence of research and academic institutes and an increasing number of clinical studies across the United States. Research-based activities in the life sciences, biotechnology, and pharmaceutical industries are an important part of North American countries ' innovation system and this is anticipated to increase the regional demand for SEM over the forecast period.

Some of the major players operating in this industry are Angstrom Advanced Inc., Bruker Corporation, Carl Zeiss, Danish Micro Engineering (DME), FEI Company, Hirox Europe Ltd., Hitachi High Technologies Corporation, JEOL Ltd, Leica Microsystems, Nanoscience Instruments, Inc., Nikon Corporation, Olympus Corporation, Tescan Orsay Holding, Thermo Fisher Scientific., ADVANTEST, COXEM Co., Ltd., and GETec Microscopy GmbH among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

Read

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

Read

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

Read

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever